NBIX - Neurocrine Biosciences Inc.

$152.57 as of 2026-08-21 · Healthcare · Drug Manufacturers - Specialty & Generic · Stock

NBIX (Neurocrine Biosciences Inc.) is the #494 most-held security of 3,078 tracked on Upside Invest, held by 5 retail investors (1% of tracked portfolios), at an average allocation of 0.3% of their portfolio.

• Popularity rank: #494 of 3,078
• Holders on Upside: 5 retail investors
• Average allocation: 0.3%
• Average holder gain/loss: +12.6%
• Stock grade: B
• 30-day trading activity: 4 buys / 0 sells
• Market cap: $15.2B

Related Healthcare securities: LLY, UNH, JNJ, HIMS, NVO

Holder statistics come from anonymized brokerage portfolios connected to Upside Invest. Join to compare your portfolio, or explore all securities.